Lonza Signs Manufacturing Deal with U.S. Biopharma Firm

Lonza says it has entered into a manufacturing services agreement with biopharmaceutical company Morphotek (Exton, PA), to support the development and manufacturing of a subset of antibodies in Morphotek’s therapeutic antibody pipeline. According to the...

This information is only available to
Chemical Week 24/7 members and subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not a Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive        access of the last 2 years        of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers